Path-breaking innovations for lung cancer: a revolution in clinical practice
AbstractLung cancer is one of main cause of death worldwide and traditional chemotherapy agents have reached the maturity phase in the treatment of advanced non-small cell lung cancer. The purpose of this paper is to analyse the evolutionary growth of knowledge patterns of vital radical innovations to treat lung cancer, driven by new technological paradigm of the targeted therapy, that have generating a revolution in clinical practice, increasing the overall survival of patients and quality of life. This new scientific pathway has evolving with an allometric process that involves a disproportionate growth of targeted therapy in relation to standard platinum-based chemotherapy alone.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by Institute for Economic Research on Firms and Growth - Moncalieri (TO) in its series CERIS Working Paper with number 201201.
Length: 26 pages Keywords : Radical Innovation, Technological Paradigm, Clinical Practice, Molecular Biology, Lung Cancer, Targeted Therapy.
Date of creation: Jun 2012
Date of revision:
Find related papers by JEL classification:
- O33 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Technological Change: Choices and Consequences; Diffusion Processes
- I1 - Health, Education, and Welfare - - Health
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology
This paper has been announced in the following NEP Reports:
- NEP-ALL-2012-06-05 (All new papers)
- NEP-HEA-2012-06-05 (Health Economics)
- NEP-HME-2012-06-05 (Heterodox Microeconomics)
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Bruno van Pottelsberghe, 2008.
"Europe's R&D: missing the wrong targets?,"
- Bruno Pottelsberghe de la Potterie, 2008. "Europe's R&D: Missing the Wrong Targets?," Intereconomics: Review of European Economic Policy, Springer, vol. 43(4), pages 220-225, July.
- Ottoz Elisabetta & Cugno Franco, 2009.
"Choosing the Scope of Trade Secret Law when Secrets Complement Patents,"
Department of Economics and Statistics Cognetti de Martiis. Working Papers
200911, University of Turin.
- Ottoz, Elisabetta & Cugno, Franco, 2011. "Choosing the scope of trade secret law when secrets complement patents," International Review of Law and Economics, Elsevier, vol. 31(4), pages 219-227.
- Ottoz, Elisabetta & Cugno, Franco, 2010. "Choosing the scope of trade secret law when secrets complement patents," MPRA Paper 20672, University Library of Munich, Germany.
- Mathieu, Azèle & van Pottelsberghe, Bruno, 2008.
"A Note on The Drivers of R&D Intensity,"
CEPR Discussion Papers
6684, C.E.P.R. Discussion Papers.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Enrico Viarisio) or (Anna Perin) or (Giancarlo Birello).
If references are entirely missing, you can add them using this form.